SURAKSHA DIAGNOSTIC LTD

SURAKSHA

Small Cap | Healthcare
₹268.1
+0.05 (+0.01%)

Stock price as on 12 Jun 2026 at 15:29 PM

Suraksha diagnostic ltd share price update

As of the latest trading session, Suraksha Diagnostic Ltd share price is currently at ₹268.1, which is up by ₹0.05 from its previous closing. Today th...

Suraksha Diagnostic Ltd stock performance

Today’s low

₹262.5

Today’s high

₹273.95

₹268.1

52 week low

₹224.1

52 week high

₹352.5

₹268.1
Open
₹262.50
Previous close
₹268.05
Share volume
22,198
Total traded value (Lakh)
₹59.50
Upper circuit
₹321.65
Lower circuit
₹214.45

Suraksha Diagnostic Ltd fundamentals

Market cap (Cr)
₹1,396.00
P/E ratio (TTM)
41.17
Book value per share
₹47.96
Beta
0.55
Return on equity
16.99%
Earnings per share (TTM)
₹6.54
Dividend yield
0.19%
Net profit/quarter (Cr)
₹6.71

Suraksha Diagnostic Ltd technical summary

₹268.05
0 ▼
9
Bearish
7
Bullish
5 Day271.1
10 Day276.4
12 Day278.2
20 Day282.4
26 Day283.4
50 Day282.4
100 Day281.2
200 Day287.3
5 Day270.4
10 Day0
12 Day0
20 Day0
26 Day0
50 Day0
100 Day0
200 Day0

269.85

PIVOT

First support
₹263.75
First resistance
₹274.15
Second support
₹259.45
Second resistance
₹280.25
Third support
₹253.35
Third resistance
₹284.55
RSI
37.61
ADX
16.71
MACD
-5.2
Williams % R
-88.99
Commodity Channel Index (CCI)
-121.01
Date
12 Jun 2026
Same day
14,048
Week
19,894
Month
28,393
1 year
0.56
3 years
0.74
Over 1 month
-8.17%
Over 1 year
-18.14%
Over 3 months
4.19%
Over 3 years
0%
Over 6 months
-5.08%
Over 6 years
0%

Investment Returns

Over 1 Month8.17%
Over 3 Months4.19%
Over 6 Months5.08%
Over 1 Year18.14%

Suraksha Diagnostic Ltd Shareholding pattern


Public
14.3%
Promoter holdings
49.09%
FII
13.45%
DII
23.13%
Promoter shares
0.1%
Promoter sharesShareCategory

Ritu Mittal

82,95,437 (15.93%)

Shareholding of Promoter and Promoter Group

Orbimed Asia Ii Mauritius Limited

67,06,711 (12.88%)

Public Shareholding

Satish Kumar Verma

56,43,971 (10.84%)

Shareholding of Promoter and Promoter Group

Sarla Kejriwal

48,09,062 (9.23%)

Shareholding of Promoter and Promoter Group

Nippon Life India Trustee Ltd-a/c Nippon India Pha

38,96,349 (7.48%)

Public Shareholding

Promoter sharesShareCategory
Ritu Mittal82,95,437 (15.93%)Shareholding of Promoter and Promoter Group
Orbimed Asia Ii Mauritius Limited67,06,711 (12.88%)Public Shareholding
Satish Kumar Verma56,43,971 (10.84%)Shareholding of Promoter and Promoter Group
Sarla Kejriwal48,09,062 (9.23%)Shareholding of Promoter and Promoter Group
Nippon Life India Trustee Ltd-a/c Nippon India Pha38,96,349 (7.48%)Public Shareholding
Kotak Small Cap Fund32,21,462 (6.19%)Public Shareholding
Somnath Chatterjee26,54,768 (5.1%)Shareholding of Promoter and Promoter Group
Tinni Investments Limited24,07,000 (4.62%)Shareholding of Promoter and Promoter Group
Aditya Birla Sun Life Trustee Private Limited A/c19,74,513 (3.79%)Public Shareholding
Dneema Overseas Private Limited16,69,562 (3.21%)Shareholding of Promoter and Promoter Group
Carnelian Bharat Amritkaal Fund12,32,306 (2.37%)Public Shareholding
Bandhan Balanced Advantage Fund6,88,395 (1.32%)Public Shareholding
Jm Financial Mutual Fund-jm Value Fund5,22,869 (1%)Public Shareholding
Aparajita Chatterjee52,533 (0.1%)Shareholding of Promoter and Promoter Group
Bipul Mittal21,060 (0.04%)Shareholding of Promoter and Promoter Group
Bipul Mittal Huf16,720 (0.03%)Shareholding of Promoter and Promoter Group
Suryamukhi Bhattacharya102 (0%)Shareholding of Promoter and Promoter Group

About SURAKSHA DIAGNOSTIC LTD

Suraksha Diagnostic Limited was incorporated as Suraksha Diagnostic Private Limited' as a private limited company dated March 15, 2005, issued by the Deputy Registrar of Companies, West Bengal at Kolkata. Subsequently, Company was converted into a public limited company and the name of Company was changed to Suraksha Diagnostic Limited', and a fresh certificate of incorporation dated July 16, 2024, was issued by the Registrar of Companies, Central Processing Centre. The Company is mainly engaged in running diagnostic centres for carrying o

Parent Organisation

Indian Private

NSE Symbol

SURAKSHA

Founded

2005

SURAKSHA DIAGNOSTIC LTD CORPORATE ACTION

No data available.

View more stocks

What’s trending

All stocks

BETA

BETA DRUGS LIMITED

1771.2
+295.2 (+20%)
RELCHEMQ

RELIANCE CHEMOTEX INDUSTRIES L

142.8
+23.8 (+20%)
IFCI

IFCI LTD.

84.63
+14.1 (+19.99%)
IFCI

IFCI LTD

84.57
+14.09 (+19.99%)
View all

Top gainers

SHRIRAMFIN

SHRIRAM FINANCE LIMITED

954.95
+68.70 (+7.75%)
BAJFINANCE

BAJAJ FINANCE LIMITED

918.3
+47.75 (+5.49%)
LT

LARSEN & TOUBRO LTD.

4049.3
+187.30 (+4.85%)
INDIGO

INTERGLOBE AVIATION LTD

4709.7
+207.30 (+4.60%)
View all

Top losers

NESTLEIND

NESTLE INDIA LIMITED

1375.7
-46.80 (-3.29%)
ONGC

OIL AND NATURAL GAS CORP.

246.2
-6.40 (-2.53%)
TECHM

TECH MAHINDRA LIMITED

1429.2
-35.90 (-2.45%)
SBILIFE

SBI LIFE INSURANCE CO LTD

1706
-13.10 (-0.76%)
View all

Frequently asked questions



Related tags


You are here


Related links


Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer

Powered by Bajaj Financial Securities Limited (Bajaj Broking)